Last reviewed · How we verify

NCT02574247

Role of the Auditory Efferent System in Auditory Perceptual Learning

Terminated NA Results posted Last updated 5 January 2018
What this trial tests

NA trial testing Computerized auditory training in Auditory Training and Auditory Efferent System in 28 participants. Terminated before completion.

Timeline
29 March 2016
Primary endpoint
17 May 2017
17 May 2017

Quick facts

Lead sponsorVA Loma Linda Health Care System
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment28
Start date29 March 2016
Primary completion17 May 2017
Estimated completion17 May 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Loma Linda Health Care System — full company profile →

Who can join

Adults 35 to 89, any sex, with Auditory Training and Auditory Efferent System. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Magnitude of Medial Olivocochlear Reflex Inhibition Primary · First and last measurements (baseline and last session up to a year later)

Decibel difference in medial olivocochlear reflex inhibition computed between final visit and baseline visit, where medial olivocochlear reflex inhibition is quantified as amplitude difference (in decibels) between transient-evoked otoacoustic emissions obtained with versus without broadband noise presented to the contralateral ear.

GroupValue95% CI
Training-0.82-3.71 – -0.08
Control-0.49-1.23 – 0.49
Association Between Medial Olivocochlear Reflex Inhibition and Untrained Speech Perception Tasks Primary · Baseline (First study visit - 3 hour session)

Spearman rank correlation computed between medial olivocochlear reflex inhibition (in decibels) and performance (in percent correct) on Coordinate Response Measure (CRM) task and Institute of Electrical and Electronics Engineers (IEEE) sentences, each presented at two decibel signal-to-noise ratios (dB SNR). Results obtained at first study visit.

CRM at -9 dB SNR
GroupValue95% CI
Pooled Participant Data-0.18
CRM at -6 dB SNR
GroupValue95% CI
Pooled Participant Data0.28
IEEE at -6 dB SNR
GroupValue95% CI
Pooled Participant Data-0.06
IEEE at -3 dB SNR
GroupValue95% CI
Pooled Participant Data0.45
Change in Auditory Training Sentence Task Performance Secondary · First and last measurements (baseline and last session up to a year later)

Difference in percent correct of auditory training sentences, computed between first and last measurements.

GroupValue95% CI
Training3-2 – 12
Change in Auditory Training Phoneme Task Performance Secondary · First and last measurements (baseline and last session up to a year later)

Difference in signal-to-noise ratio (in decibels) on auditory training phoneme tasks (onsets, nuclei, and codas), computed between first and last measurement.

Onsets
GroupValue95% CI
Training-4.38-22.98 – -1.99
Nuclei
GroupValue95% CI
Training-2.99-6.14 – 2.83
Codas
GroupValue95% CI
Training-2.60-10.99 – 10.37
Association Between Medial Olivocochlear Reflex Inhibition and Slope of the Psychometric Function of Untrained Speech Perception Tasks Secondary · Baseline (First study visit - 3 hour session)

Partial Spearman rank correlation computed between medial olivocochlear reflex inhibition (in decibels) and slope of the psychometric function (in decibel per decibel) of untrained speech tasks (Coordinate Response Measure -- CRM; Institute of Electrical and Electronics Engineers -- IEEE) obtained from performance across two signal-to-noise ratios. Age and high-frequency pure-tone average were controlled for in this post-hoc analysis. Results obtained at first study visit.

CRM Slope
GroupValue95% CI
Pooled Participant Data0.59
IEEE Slope
GroupValue95% CI
Pooled Participant Data0.60

Adverse events — posted to ClinicalTrials.gov

Time frame: Through study completion, maximum of 1 year.. Reporting threshold: 5%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Training
Serious: 0/10 (0%)
Deaths: 0/10
Control
Serious: 0/8 (0%)
Deaths: 0/8
Speech Group
Serious: 0/10 (0%)
Deaths: 0/10
Other adverse events (1 terms — click to expand)

ReactionSystemTrainingControlSpeech Group
Gastrointestinal painGastrointestinal disorders

Data from ClinicalTrials.gov NCT02574247 adverse events section.

Sponsor's own description

The purpose of this study is to determine how changes in speech perception resulting from a computerized auditory training program are related to concurrent changes in auditory brainstem function resulting from the training. It is hypothesized that the degree of improvement in speech perception will be correlated with the degree of change in brainstem function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Olivocochlear Efferent Activity Is Associated With the Slope of the Psychometric Function of Speech Recognition in Noise.
    Mertes IB, Wilbanks EC, Leek MR. · · 2018 · cited 22× · PMID 29135685 · DOI 10.1097/aud.0000000000000514

Verify or expand the search:

Other VA Loma Linda Health Care System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02574247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing